MYC and breast cancer: Specifically, miR-193a-3p affects five key signaling pathways, including DNA damage, Notch, NF-κB, Myc/Max, and oxidative stress, by targeting downstream genes such as SRSF2, PLAU, and HIC2, thereby further enhancing resistance to multiple chemotherapies in BC cells (127).